Wellnex Life (ASX:WNX): Q1 FY25 Quarterly Report and Appendix 4C

Wellnex Life Limited (Wellnex, WNX or Company) (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently published a key ASX announcement. 

Wellnex Life Limited (ASX) ("Wellnex Life" or the "Company"), is pleased to share the Q1 FY25 results, showing significant momentum in the health and wellness space! 🌱

Announcement Highlights

• Record Brand Sales: Achieving $4.1 million in cash inflows this quarter.
• Global Expansion: First orders from Haleon for the UK market, bringing Wellnex products to a trusted global stage.
• Strategic Growth: Ongoing plans for a dual listing on the London Stock Exchange and a strengthened board with industry expertise.
  

With these milestones, Wellnex Life is well-positioned for further growth in both Australian and international markets. 🌍 A huge congratulations to George Karafotias, Zack Bozinovski, the board and the team at WNX for reaching this milestone.

Read the full Wellnex Life Company Update here.

To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.